Virios Therapeutics, Inc. (NASDAQ:VIRI - Get Free Report)'s stock price was down 7.5% during trading on Wednesday . The company traded as low as $4.64 and last traded at $4.70. Approximately 59,460 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 1,049,645 shares. The stock had previously closed at $5.08.
Virios Therapeutics Stock Up 1.5%
The company has a market capitalization of $93.02 million, a PE ratio of -17.89 and a beta of 1.58. The stock's fifty day simple moving average is $4.99 and its 200-day simple moving average is $5.58.
Virios Therapeutics Company Profile
(
Get Free Report)
Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.
Featured Articles
Before you consider Virios Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Virios Therapeutics wasn't on the list.
While Virios Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
